Results 91 to 100 of about 3,130,322 (229)
Surgical management of anastomotic leakage related to ovarian cancer surgery: a narrative review
This narrative review describes the state of the art in the management of anastomotic leakage in ovarian cancer. Multiple surgical procedures, including bowel resection, are often required to achieve “optimal” cytoreduction in locally advanced ovarian ...
S. Restaino +19 more
semanticscholar +1 more source
Integrated multi‐omics identified key genes associated with the immune microenvironment in ovarian cancer, and functional assays validated the role of key genes in ovarian cancer. ABSTRACT Ovarian cancer (OC) is one of the most aggressive gynecological malignancies worldwide.
Wenshu Leng, Xingyue Fan, Yichen Fang
wiley +1 more source
Background and Aims: This study aims to trans oesophageal echo cardiographically (TOE) measure inferior venacava diameter (IVCD) during inspiration and expiration in poor left ventricular ejection fraction (LVEF) patients undergoing cytoreductive ...
Shagun Bhatia Shah +5 more
doaj +1 more source
Surgical treatment of recurrent endometrial cancer with a pelvic abscess: a clinical case
The article presents a clinical case of a patient with stage IA endometrial cancer, who, at a later date following specialized treatment conducted according to established standards, was diagnosed with disease progression complicated by an abscess in the
A. S. Yamshchikova +9 more
semanticscholar +1 more source
Objectives To evaluate the clinical outcomes of epithelial ovarian carcinoma patients who underwent cardiophrenic lymph node resection. Methods We retrospectively reviewed the records of all surgically treated patients with advanced epithelial ovarian ...
A. Lopes +13 more
semanticscholar +1 more source
ABSTRACT Background Endocrine therapy with CDK4/6 inhibitor has been the main treatment for HR+/HER2− breast cancer in the adjuvant setting; however, the data on the application in the neoadjuvant setting is limited. We compared neoadjuvant efficacy and safety of sequential chemotherapy‐CDK4/6 inhibitors with chemotherapy alone in HR+/HER2− breast ...
Xiaopei Dong +10 more
wiley +1 more source
PD‐L1 in Ovarian Cancer: Immune Evasion, Tumor‐Intrinsic Signaling, and Chemoresistance
The “Dual Shield” model of PD‐L1 in ovarian cancer. On the outside, PD‐L1 engages PD‐1 to inactivate T cells and drive immune evasion (immune shield). Inside the tumor cell, PD‐L1 activates AKT–mTOR, enhances DNA repair, rewires metabolism, supports autophagy, and enforces stemness programs—collectively creating a chemoresistance shield.
Zhiyang Xu +3 more
wiley +1 more source
Comparison of P53 mutation status, primary cytoreductive surgical outcomes, and overall survival in patients with ovarian cancer [PDF]
Optimal surgical cytoreduction continues to be an important prognostic variable in patients with ovarian cancer independent of p53 mutational status.
Collins, K +17 more
core +1 more source
Procedures in emergency medicine: surgical cricothyroidotomy
This video is part of a series of videos demonstrating common procedures performed in the Emergency Medicine setting. It was prepared by Cape Town Emergency Medicine's consultants and registrars.
Oosthuizen, Almero +1 more
core +1 more source

